A Smadトランスクリプションコアプレッサー
1Cell Biology Program, Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Cell
|April 13, 1999
まとめ
この研究は,核内のSmad2-Smad4複合体が転写を活性化したり抑制したりすることを明らかにしています. このスイッチは,彼らがコアクティベーターまたはTGIFおよびヒストン脱酸化酵素 (HDAC) を採用するかどうかに依存します.
科学分野:
- 分子生物学は分子生物学である.
- 細胞シグナリング 細胞シグナリング
- 遺伝子規制 遺伝子規制
背景:
- 成長因子β (TGF-β) 信号の変換は,細胞プロセスにとって極めて重要です.
- Smadタンパク質,特にSmad2とSmad4は,TGF-βの主要な媒介者である.
- Smad複合体による転写調節には,コアクティベーターとコアプレッサーとの相互作用が含まれます.
研究 の 目的:
- Smad2媒介の転写調節のメカニズムを調査する.
- 新しいSmad2相互作用タンパク質を特定するために.
- TGF-βシグナル伝達におけるTGIFの役割を明らかにする.
主な方法:
- 同免疫プレシピテーションは,Smad2結合タンパク質を特定するための測定法です.
- レポーター遺伝子解析は,転写活動の測定を目的としています.
- プロモーター結合を評価するためのクロマチンの免疫プレシピテーション.
主要な成果:
- TGIFは,新しいSmad2結合タンパク質として特定されました.
- TGIFは,転写抑制剤として機能する.
- Smad複合体は,活性化のためにコアクティベーター (p300/CBPのような) または,抑制のためにTGIFおよびヒストン脱酸化酵素 (HDACs) を採用することができます.
結論:
- Smad2-Smad4による転写活性化または抑制複合体の形成は,文脈に依存しています.
- コアクティベーターとコアプレッサー (TGIF/HDACsなど) のバランスが,転写結果を決定する.
- これは,TGF-β応答を微調整するための新しいメカニズムを提供します.
関連する概念動画
Nuclear Export of mRNA
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Nuclear Export of mRNA
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Introduction to Nuclear Reprogramming
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.


